Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 71

1.

Mind the Gap: Why Closing the Doughnut Hole Is Insufficient for Increasing Medicare Beneficiary Access to Oral Chemotherapy.

Dusetzina SB, Keating NL.

J Clin Oncol. 2016 Feb 1;34(4):375-80. doi: 10.1200/JCO.2015.63.7736. Epub 2015 Dec 7.

PMID:
26644524
2.

Did Medicare Part D Affect National Trends in Health Outcomes or Hospitalizations? A Time-Series Analysis.

Briesacher BA, Madden JM, Zhang F, Fouayzi H, Ross-Degnan D, Gurwitz JH, Soumerai SB.

Ann Intern Med. 2015 Jun 16;162(12):825-33. doi: 10.7326/M14-0726.

3.

Cost-Related Medication Nonadherence and Cost-Saving Behaviors Among Patients With Glaucoma Before and After the Implementation of Medicare Part D.

Blumberg DM, Prager AJ, Liebmann JM, Cioffi GA, De Moraes CG.

JAMA Ophthalmol. 2015 Sep;133(9):985-96. doi: 10.1001/jamaophthalmol.2015.1671.

PMID:
26042393
4.

Does good medication adherence really save payers money?

Stuart BC, Dai M, Xu J, Loh FH, S Dougherty J.

Med Care. 2015 Jun;53(6):517-23. doi: 10.1097/MLR.0000000000000360.

PMID:
25961659
5.
6.

Persistent medication affordability problems among disabled Medicare beneficiaries after Part D, 2006-2011.

Naci H, Soumerai SB, Ross-Degnan D, Zhang F, Briesacher BA, Gurwitz JH, Madden JM.

Med Care. 2014 Nov;52(11):951-6. doi: 10.1097/MLR.0000000000000205.

7.

Out-of-pocket costs and oral cancer medication discontinuation in the elderly.

Kaisaeng N, Harpe SE, Carroll NV.

J Manag Care Spec Pharm. 2014 Jul;20(7):669-75.

8.

US health spending trends by age and gender: selected years 2002-10.

Lassman D, Hartman M, Washington B, Andrews K, Catlin A.

Health Aff (Millwood). 2014 May;33(5):815-22. doi: 10.1377/hlthaff.2013.1224.

PMID:
24799579
9.

Use of and spending on supportive care medications among Medicare beneficiaries with cancer.

Zuckerman IH, Davidoff AJ, Erten MZ, Stuart B, Shaffer T, Dougherty JS, Yong C.

Support Care Cancer. 2014 Aug;22(8):2185-95.

PMID:
24659243
10.

Should eligibility for medication therapy management be based on drug adherence?

Stuart B, Loh E, Miller L, Roberto P.

J Manag Care Pharm. 2014 Jan;20(1):66-75.

11.

Nonlinear pricing in drug benefits and medication use: the case of statin compliance in Medicare Part D.

Jung K, Feldman R, McBean AM.

Health Serv Res. 2014 Jun;49(3):910-28. doi: 10.1111/1475-6773.12145. Epub 2013 Dec 19.

12.

Has Medicare Part D reduced racial/ethnic disparities in prescription drug use and spending?

Mahmoudi E, Jensen GA.

Health Serv Res. 2014 Apr;49(2):502-25. doi: 10.1111/1475-6773.12099. Epub 2013 Sep 18.

13.

Effects of Medicare Part D coverage gap on medication adherence.

Zhang Y, Baik SH, Lave JR.

Am J Manag Care. 2013 Jun 1;19(6):e214-24.

14.

Increasing Medicare part D enrollment in medication therapy management could improve health and lower costs.

Stuart B, Loh FE, Roberto P, Miller LM.

Health Aff (Millwood). 2013 Jul;32(7):1212-20. doi: 10.1377/hlthaff.2012.0848.

15.

Brand-name prescription drug use among Veterans Affairs and Medicare Part D patients with diabetes: a national cohort comparison.

Gellad WF, Donohue JM, Zhao X, Mor MK, Thorpe CT, Smith J, Good CB, Fine MJ, Morden NE.

Ann Intern Med. 2013 Jul 16;159(2):105-14. doi: 10.7326/0003-4819-159-2-201307160-00664.

16.

Adverse clinical events among medicare beneficiaries using antipsychotic drugs: linking health insurance benefits and clinical needs.

Fung V, Price M, Busch AB, Landrum MB, Fireman B, Nierenberg A, Dow WH, Hui R, Frank R, Newhouse JP, Hsu J.

Med Care. 2013 Jul;51(7):614-21. doi: 10.1097/MLR.0b013e31829019c5.

17.

Cognition and take-up of subsidized drug benefits by Medicare beneficiaries.

Kuye IO, Frank RG, McWilliams JM.

JAMA Intern Med. 2013 Jun 24;173(12):1100-7. doi: 10.1001/jamainternmed.2013.845.

18.

Uptake of the NHS Health Check programme in an urban setting.

Artac M, Dalton AR, Majeed A, Car J, Huckvale K, Millett C.

Fam Pract. 2013 Aug;30(4):426-35. doi: 10.1093/fampra/cmt002. Epub 2013 Feb 1.

19.

Use and spending on antineoplastic therapy for Medicare beneficiaries with cancer.

Davidoff AJ, Shaffer T, Erten MZ, Shoemaker JS, Zuckerman IH, Pandya N, Stuart BC, Bryant-Comstock LG, Shenolikar R.

Med Care. 2013 Apr;51(4):351-60. doi: 10.1097/MLR.0b013e3182726ceb.

PMID:
23222498
20.

In Medicare Part D plans, low or zero copays and other features to encourage the use of generic statins work, could save billions.

Hoadley JF, Merrell K, Hargrave E, Summer L.

Health Aff (Millwood). 2012 Oct;31(10):2266-75. doi: 10.1377/hlthaff.2012.0019.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk